Type 2 diabetes: new drugs, new perspectives.
Detection at younger ages is rapidly increasing. Although diet and exercise remain the mainstays of therapy, physicians can now choose from among a variety of medications targeting different pathophysiologic facets of the disease. The newest drugs are the thiazolidinediones, a totally novel class of insulin sensitizers.
Goldfine
A B
AB
Joslin Diabetes Center, Boston, USA.
D000328:Adult; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D003927:Diet, Diabetic; D015444:Exercise; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance
D007004:Hypoglycemic Agents; D005947:Glucose